|
|
|
|
|
|
|
|
|
|
|
|
|
| Category 2 |
Health: Education
|
|
| Category 3 |
Health: Medicine
|
|
|
|
|
| Contact |
12901 Bruce B. Downs Boulevard, MDC 46
|
|
|
|
|
|
| Description |
Adult and pediatric diabetes clinical care has changed significantly over the last
decade. Research has been completed on new therapeutic agents and approaches
to management. Research in this field continues toward prevention and cure of
type 1 and type 2 diabetes. With knowledge of alternatives to current medical care,
physicians and other providers may choose new therapies or introduce their patients
to the possibilities of prevention in their family members.
● Clinical providers depend on continuing education programs to provide the latest
information to improve care for the 23 million people with diabetes and the
millions more that are at risk for developing diabetes.
● Prevention of type 1 diabetes research includes identifying at risk family
members, including offspring, of people with type 1 diabetes. Prevention
research begins with finding those people in the community being treated by
providers not associated with research centers.
● Care of people with type 1 diabetes should include considering the possibility of
transplantation of the cells responsible for insulin production. This research is
ongoing and there are outcomes that can be shared before the completion of the
research which may impact the care of people with diabetes.
● Care of people with diabetes, type 1 or 2 must include addressing complications
that may be preventable. Research in this field includes prevention strategies and
intensive management, using treatments and tools currently available, but not
necessarily in wide use.
● There are new therapeutic agents, including some used in other countries, but not
yet available in the USA. These are on the horizon here and may be treatment
options in the future.
|
|
| Additional Information |
At the conclusion of this CME program, the attendee will be able to:
● Identify 3 current trials which are studying the prevention of diabetes.
● Describe new therapeutic agents on the horizon for the treatment of diabetes.
● Utilize tools which will help address tighter control concerns for diabetes
complication risk reduction.
● Review recent research related to the safety and efficacy of oral insulin.
● Describe recent advances in the treatment of type 1 diabetes in childhood
including the application of continuous glucose monitoring to clinical care.
● Explore advances in diagnosis and treatment of type 2 diabetes, including the
use of newer drugs and the earlier introduction of insulin therapy.
● Describe the role of the immune system in the pathogenesis of type 1 diabetes
and clinical trials designed to modify immune response.
● Describe the mechanisms and roadblocks to successful islet cell transplantation
in patients with type 1 diabetes.
|
|
